Knowledge base · Peer-reviewed

ScaleWiki.

Peer-reviewed manuscripts on the G-Rex® platform — one citable page per paper, curated so you find the evidence that moves your cell & gene therapy program forward.

487Manuscripts indexed
14Cell types
Live indexContinuously updated

Showing 12 of 530 resources

Publications T-Cells G-Rex®24 Well Plate

Publication Date: December 31, 2024

Extracellular viral microRNAs as biomarkers of virus infection in human cells

Extracellular viral microRNAs (exmiRs) in spent culture media or plasma served as candidate biomarkers of live, latent and reactivated virus infections of human cells, with results in about 20 hours. Extracellular RNA was captured by overnight polyethylene glycol precipitation and read by stem-loop RT-qPCR; most of 25 viral miRNA assays quantified down to about 33 aM. In healthy-donor T cells, live EBV-2 gave about 3-fold more miR-BART10-3p, and live HSV-1 up to about 20-fold more miR-H5, than heat-inactivated or antibody-neutralized virus. HSV miR-H2 was detectable 8 h after infection. HHV-6 miR-Ro6-4 flagged latent HHV-6 in one of four donors, two HCMV exmiRs were found in plasma of all…

Download Now →

Author: Cheryl Chan, Joanne Xin Yi Loh +9 more

Publications TCR T Cells G-Rex®24 Well Plate

Publication Date: December 30, 2024

Targeting of acute myeloid leukemia by five-gene engineered T cells expressing transgenic T-cell receptor specific to WT1, chimeric antigenic receptor specific to GM-CSF receptor, bispecific T-cell engager specific to CD33 and tEGFR suicide gene system

T cells engineered with a single piggyBac transposon to carry a WT1-specific TCR, an NFAT-inducible GM-CSF receptor CAR, a secreted CD3xCD33 bispecific engager and a tEGFR suicide marker showed stronger anti-leukemic activity in vitro than TCR-only T cells. Inducible CAR expression improved killing of THP-1 cells and primary AML cells from HLA-A2 positive patients and was sensitive to cyclosporine. Adding the engager enabled killing of THP-1 targets at an effector-to-target ratio of 1:32-64, versus 1:8-16 without it and 1:2-4 for TCR-only cells. In primary AML co-cultures, about 1.2% of AML cells remained with engager cells, versus 6.5% without. The engager also eliminated CD33-positive b…

Download Now →

Author: Kristýna Šmilauerová, Martin Štach +4 more

Publications Other G-Rex®6 Well Plate

Publication Date: December 17, 2024

Human keratinocytes grown at a gas-permeable interface in vitro stratify correctly to generate engineered human epidermis

Human keratinocytes cultured on a gas-permeable membrane at the base of a sealed vessel stratified into a full epidermis comparable to that produced by the traditional air-liquid interface. Keratinocytes from skin digests were seeded onto de-epithelialized human dermis at about 600,000 cells/cm2 and cultured for 14 days. Both methods gave complete stratification with a fully differentiated Stratum Corneum, and Cytokeratin 14, Cytokeratin 10, Filaggrin and Loricrin patterns resembled human skin. Claudin-1 was expressed in three of four donors. Gas-permeable culture needed no medium monitoring or changes once 20 mL of medium was added, which reduces handling, contamination risk and staff wo…

Download Now →

Author: Vaughan Feisst, Lisa Y.Y. Zhou +14 more

Publications CAR T Cells G-Rex®100

Publication Date: December 7, 2024

Accelerating CAR T cell manufacturing with an automated next-day process

A semi-automated 24-hour CAR T cell process produced a less differentiated, less exhausted product than a 7-day process with ex vivo expansion. T cells from three healthy donor leukopaks were isolated and activated with detachable CD3/CD28 beads (86% average isolation efficiency), transduced with an anti-CD19 CAR lentivirus at MOI 2 for about 20 hours, then washed and cryopreserved. Post-formulation T cell recovery averaged 82% versus 78%, and both products exceeded 95% T cell purity. The 24-hour process yielded 520 million CAR-expressing T cells versus 3.4 billion after 7-day expansion. After thawing, 24-hour cells expanded about 9.3-fold by day 4 versus 4.8-fold, showed fewer PD-1+ and…

Download Now →

Author: Moloud Ahmadi, Nicholas Putnam +8 more

Publications CAR T Cells G-Rex®24 Well Plate

Publication Date: December 5, 2024

Increased functional potency of multi-edited CAR-T cells manufactured by a non-viral transfection system

Solupore, a non-viral physicochemical transfection system, produced triple-edited (TRAC, B2M, CD7) CD19 CAR-T cells that performed better than electroporated cells in a simulated manufacturing process. Healthy-donor T cells were edited with CRISPR-Cas9 ribonucleoproteins, transduced with a lentiviral CD19 CAR and cryopreserved. Thirty minutes after transfection, 12% of Solupore-treated cells were apoptotic versus 24% after electroporation. After thawing, over 70% of Solupore CAR-T cells remained bound to Raji targets at 1,000 pN, compared with just over 38% of electroporated cells, and Solupore cells killed Raji and Nalm-6 cells more effectively. In NSG mice dosed with 4 × 10^6 cells, Sol…

Download Now →

Author: Aine O’Sullivan, Sarah Case +13 more

Publications TIL Cells

Publication Date: December 2, 2024

Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers

Neoantigen-reactive tumor-infiltrating lymphocytes (TILs) can be screened for and manufactured under GMP conditions, supporting a phase I trial in advanced epithelial and checkpoint-resistant solid cancers. TILs expanded from 82% of core tumor biopsies, and nine of ten patients tested had pre-REP cultures reactive to autologous tumor cell lines. Whole-exome-guided screening found neoantigen-reactive cultures in all four patients tested. Six pre-REP validations were run at a GMP facility, with a median 25 days in culture, and three rapid-expansion finished products reached 4.3e9 to 1.1e11 viable cells within specifications. The single-center, open-label NEXTGEN-TIL trial (NCT05141474) sele…

Download Now →

Author: J. Palomero, V. Galvao +31 more

Publications CAR T Cells G-Rex®6M Well Plate

Publication Date: November 22, 2024

Affinity-tuned mesothelin CAR T cells demonstrate enhanced targeting specificity and reduced off-tumor toxicity

Tuning the affinity of a mesothelin-specific nanobody CAR reduced fatal on-target, off-tumor toxicity in mouse models. Alanine scanning of the nanobody CDRs produced variants with a wide affinity range, and the N9A variant bound human mesothelin about 500-fold more weakly than the parental clone. In vitro, only N9A CAR T cells killed in proportion to mesothelin density. In mice bearing MSTO-211H/hMSLN tumors, high-affinity CAR T cells caused severe toxicity and expanded in lungs, liver and bone marrow, whereas N9A cells regressed tumors, homed to the tumor and showed little off-tumor expansion. The nanobody cross-reacts with mouse mesothelin, enabling this safety assessment.

Download Now →

Author: Yanping Yang, Yogindra Vedvyas +7 more

Publications TCR T Cells G-Rex®24 Well Plate

Publication Date: November 8, 2024

Rapid parallel reconstruction and specificity screening of hundreds of T cell receptors

A medium-throughput pipeline reconstructed and screened roughly one hundred T cell receptors in parallel over about two months. Receptor blocks were cloned by Gibson assembly in 96-well format, lentivirus was produced by miniaturized transfection in 96-well plates, and transduced primary T cells expanded for 8 to 14 days before testing. Staining with three CellTrace dyes at up to four concentrations distinguished as many as 64 effector lines pooled together, with CD137 upregulation read by flow cytometry. Primary T cells reached half-maximal activation at antigen doses 15-fold lower than T cell receptor knockout Jurkat cells. Applied to glioblastoma tumor-infiltrating lymphocytes, 102 of…

Download Now →

Author: Alexander B. Afeyan, Catherine J. Wu +1 more

Publications CAR T Cells, NK Cells G-Rex®24 Well Plate

Publication Date: October 24, 2024

Optimizing the procedure for manufacturing clinical-grade genetically manipulated natural killer cells for adoptive immunotherapy

Feeder-cell expansion of NK cells from frozen peripheral blood mononuclear cells was compared across six commercial media and four supplements, giving 24 formulations. KBM581 with Immune Cell Serum Replacement gave the greatest expansion at day 14, about 5218-fold, and 25411-fold by day 21. KBM581 with human AB serum gave the strongest cytotoxicity against K562 cells. Baboon envelope lentivirus transduced NK cells robustly, whereas the hybrid baboon-VSVG envelope gave under 10% efficiency. B2M knockout by nucleofection with the DN-100 program balanced editing efficiency and expansion when done on days 4 to 6 after feeder-cell activation. The authors note the small sample size.

Download Now →

Author: Haolong Lin, Shanwei Ye +6 more

Publications T-Cells

Publication Date: October 20, 2024

Expansion and Precise CRISPR-Cas9 Gene Repair of Autologous T-Memory Stem Cells from Patients with T-Cell Immunodeficiencies

Human T memory stem cell-like populations can be expanded from a small number of peripheral blood mononuclear cells and precisely gene-repaired, using perforin (PRF1) as the example target. Cells were activated with CD3/CD28/CD2 reagent plus IL-7 and IL-15, and CD8+ T cells expanded 600–700-fold from a patient sample. After ten days, over 90% of CD8+ cells were stem-cell-like without exhaustion signs. Editing combined Cas9 ribonucleoprotein electroporation, AAV6 donor delivery and the DNA-PK inhibitor M3814. Two gRNAs gave median allele editing of about 60% (strategy 1) and 40% (strategy 2), and more than 75% of edited cells kept the phenotype.

Download Now →

Author: Xun Li, Van Trung Chu +2 more

Publications TCR T Cells G-Rex®6 Well Plate

Publication Date: October 17, 2024

In silico and pharmacological evaluation of GPR65 as a cancer immunotherapy target regulating T-cell functions

Inhibiting the proton-sensing receptor GPR65 enhanced the anti-tumour activity of antigen-specific human T-cells in vitro. Analysis of public TCGA and single-cell datasets showed that tumour-infiltrating CD8+ T-cells express GPR65 mRNA, and that homozygosity for the partial loss-of-function variant rs3742704 correlated with better survival in patients diagnosed at early stages. In co-cultures of NY-ESO1 or MAGE-A4 TCR T-cells with A375 melanoma cells, GPR65 agonists reduced killing. Four small-molecule antagonists were validated by blocking pH-dependent cAMP induction. SD2758 and SD2571 increased tumour cell killing, maintained over 10 days with rechallenges, and SD2758 raised IFN-γ and T…

Download Now →

Author: Shamin Li, Fabien Melchiore +11 more

Publications Other

Publication Date: October 15, 2024

Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors

A single intravenous dose of T cells engineered with a Claudin 18.2 (CLDN18.2)-directed T-cell antigen coupler cleared established gastric, gastroesophageal and pancreatic tumor xenografts in mice without evidence of on-target/off-tumor effects. At 6 × 10^6 TAC-positive cells per mouse, OE19, PANC 05.04 and CLDN18.2-overexpressing N87 tumors were completely cleared 24 days after adoptive cell transfer or earlier, while PA-TU 8988S growth was inhibited by 83% at day 30. In coculture, activation and killing occurred only with CLDN18.2-expressing targets, not with CLDN18.1-engineered cells or primary cells from normal human tissues, and killing continued over 12 consecutive rounds across 48…

Download Now →

Author: Stacey X. Xu, Ling Wang +15 more